FIELD: chemistry.
SUBSTANCE: invention relates to diastereomers of isobornyl compounds of the structural formula (I), where R1=H and isobornyl fragments have the configuration (1S, 2R, 4R, 1'S, 2'R, 4'R) and (1R, 2S, 4S, 1'R, 2'S, 4'S), where R1=CH3 and isobornyl fragments have the configuration (1S, 2R, 4R, 1'R, 2'S, 4'S) or the isobornyl fragments have the configuration (1S, 2R, 4R, 1'S, 2'R, 4'R) and (1R, 2S, 4S, 1'R, 2'S, 4'S).
EFFECT: high antioxidant activity.
1 ex
Title | Year | Author | Number |
---|---|---|---|
2,6-DIISOBORNYL PHENOL DERIVATIVES | 2011 |
|
RU2575294C2 |
NOVEL DERIVATIVES OF 2,6-DI-ISOBORNYL PHENOL AND METHOD OF OBTAINING THEREOF | 2012 |
|
RU2516699C2 |
TETRA-(MESO-ARYL)-PORPHYRIN WITH DIISOBORNYLPHENOL SUBSTITUTES IN MACROCYCLE | 2012 |
|
RU2496761C1 |
DRUG WITH COMPLEX PHARMACOLOGICAL EFFECT FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CORRECTION OF CEREBRAL CIRCULATION DISORDERS, TREATMENT OF CONSEQUENCES OF CEREBROVASCULAR DISEASES (OPTIONS) | 2019 |
|
RU2757874C1 |
PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
N-BORNIL- AND N-PHENCHYLCARBOXAMIDES USED AS ORTHOPOXVIRUS REPLICATION INHIBITORS | 2022 |
|
RU2800448C1 |
APOPTOSIS INDUCING AGENTS FOR TREATING CANCER, IMMUNE AND AUTOIMMUNE DISEASES | 2011 |
|
RU2568611C2 |
NEW ARYLATED CAMPHENES, METHODS FOR PRODUCING AND USING THEM | 2010 |
|
RU2578715C2 |
HYDROPHILIC CONCENTRATE OF DERIVATIVE STARCH, AND 2,6-DIIZZBORNIL-4-METHYLPHENOL AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2619934C2 |
BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
Authors
Dates
2013-12-27—Published
2011-07-06—Filed